A pharmacokinetic and pharmacodynamic study of desmopressin: Evaluating sex differences and the effect of pre-treatment with piroxicam, and further validation of an indirect response model

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 11, 2004, Pages 1389-1398

  Odeberg, Johanna Mercke ^a   Callréus, Torbjörn ^a   Lundin, Stefan ^a   Roth, E Bodil ^a   Höglund, Peter ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ADULT; ARTICLE; BOLUS INJECTION; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES INSIPIDUS; DIURESIS; DRUG EFFECT; DRUG INFUSION; DRUG SYNTHESIS; FEMALE; FEVER; HUMAN; HUMAN EXPERIMENT; INDIRECT RESPONSE MODEL; INFLUENZA; MALE; MICTURITION; NOCTURIA; NORMAL HUMAN; PROSTAGLANDIN RELEASE; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM; SEX DIFFERENCE; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STEADY STATE; URINE OSMOLALITY;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; DEAMINO ARGININE VASOPRESSIN; DIABETES INSIPIDUS; DRUG INTERACTIONS; FEMALE; HEMOSTATICS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PIROXICAM; SEX FACTORS;

EID: 8144226234     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357044535     Document Type: Article

References (30)

1. Agnoli, G. C., Borgatti, R., Cacciari, M., Lenzi, P., Marinelli M., Stipo, L. (2002) Low-dose desmopressin infusion: renal action in healthy women in moderate salt retention and depletion, and interactions with prostanoids. Prostaglandins Leukol. Essent. Fatty Acids 67: 263-273
2. Beierle, L, Meibohm, B., Derendorf, H. (1999) Gender differences in pharmacokinetics and pharmacodynamics. Int. J. Clin. Pharmacol. Ther. 37: 529-547
3. Breyer, M. D., Breyer, R. M. (2000) Prostaglandin E receptors and the kidney. Am. J. Physiol. Renal Physiol. 279: F12-F23
4. Callréus, T., Höglund, P. (1998) Pharmacokinetics and anti-diuretic effect of intravenous administration of desmopressin in orally overhydrated male volunteers. Pharmacol. Toxicol. 83: 259-262
5. Callréus, T., Odeberg, J., Lundin S., Höglund, P. (1999) Indirect-response modeling of desmopressin at different levels of hydration. J. Pharmacokinet. Biopharm. 27: 513-529
6. Chang, W. C. (1988) Stimulation of prostaglandin E2 biosynthesis by estradiol in rat kidneys. Prostaglandins Leukot. Essent. Fatty Acids 33: 159-163
7. Dayneka, N. L., Garg, V., Jusko, W. J. (1993) Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokinet. Biopharm. 21: 457-478
8. Dollery, C. (1999) Desmopressin (acetate). In: Bobbis, A., Rawlins, M., Thomas, S., Wilkins, M. (eds) Therapeutic drugs. Churchill Livingstone, Edinburgh, pp D39-D42
9. Dusing, R., Herrmann, R., Glanzer, K., Vetter, H., Overlack, A., Kramer, H. J. (1981) Renal prostaglandins and water balance: studies in normal volunteer subjects and in patients with central diabetes insipidus. Clin. Sci. (Lond.) 61: 61-67
10. Fjellestad-Paulsen, A., Höglund, P., Lundin, S., Paulsen, O. (1993) Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers. Clin. Endocrinol. (Oxf.) 38: 177-182
11. Geelen, G., Greenleaf, J. E., Keil, L. C. (1996) Drinking-induced plasma vasopressin and norepinephrine changes in dehydrated humans. J. Clin. Endocrinol. Metab. 81: 2131-2135
12. Gilbaldi, M., Perrier, D. (1982) Pharmacokinetics. Marc Dekker Inc, New York
13. Harris, R. Z., Benet, L. Z., Schwartz, J. B. (1995) Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50: 222-239
14. Jackson, E. K. (2001) Vasopressin and other agents affecting the renal conservation of water. In: Hardman, J. G., Limbird, L. E. (eds) Goodman & Gilman's: The pharmacological basis of therapeutics. McGraw-Hill, USA, pp 789-808
15. Jackson Roberts, L. R., Morrow, J. D. (2001) Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Hardman, J. G., Limbird, L. E. (eds) Goodman & Gilman's: The pharmacological basis of therapeutics. McGraw-Hill, USA. pp 687-731
16. Juhlin, T., Björkman, S., Gunnarsson, B., Fyge, Å., Roth, B., Höglund, P. (2004) Acute administration of diclofenac, but possibly not long term low dose aspirin, causes detrimental renal effects in heart failure patients treated with ACE-inhibitors. Eur. J. Heart Failure In press
17. Lam, K. S., Wat, M. S., Choi, K. L., Ip, T. P., Pang, R. W., Kumana, C. R. (1996) Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus. Br. J. Clin. Pharmacol. 42: 379-385
18. Lethagen, S., Frick, K., Sterner, G. (1998) Antidiuretic effect of desmopressin given in hemostatic dosages to healthy volunteers. Am. J. Hematol. 57: 153-159
19. Lundin, S., Melin, P., Vilhardt, H. (1985) Plasma concentrations of 1-deamino-8-D-arginine vasopressin after intragastric administration in the rat. Acta Endocrinol. (Copenh.) 108: 179-183
20. Moses, A. M., Moses, L. K., Notman, D. D., Springer, J. (1981) Antidiuretic responses to injected desmopressin, alone and with indomethacin. J. Clin. Endocrinol. Metab. 52: 910-913
21. Olkkola, K. T., Brunetto, A. V., Mattila, M. J. (1994) Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. Clin. Pharmacokinet. 26: 107-120
22. Pedersen, R. S., Bentzen, H., Bech, J. N., Pedersen, E. B. (2001) Effect of an acute oral ibuprofen intake on urinary aquaporin-2 excretion in healthy humans. Scand. J. Clin. Lab. Invest. 61: 631-640
23. Rado, J. P., Marosi, J., Szende, L., Borbely, L., Tako, J., Fischer, J. (1976) The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man. Int. J. Clin. Pharmacol. Biopharm. 13: 199-209
24. Richardson, C. J., Blocka, K. L., Ross, S. G., Verbeeck, R. K. (1985) Effects of age and sex on piroxicam disposition. Clin. Pharmacol. Ther. 37: 13-18
25. Robson, W. L., Norgaard, J. P., Leung, A. K. (1996) Hyponatremia in patients with nocturnal enuresis treated with DDAVP. Eur. J. Pediatr. 155: 959-962
26. Shindel, A., Tobin, G., Klutke, C. (2002) Hyponatremia associated with desmopressin for the treatment of nocturnal polyuria. Urology 60: 344
27. Sjöstrand, U., Wickström, I. (1990) Dehydrering and hyperhydrering. In: Mossberg, T. (ed.) Praktisk vätsketerapi. Nordstedts Förlag AB, Almqvist & Wiksell, Stockholm, pp 22-29
28. Tryding, N., Sterner, G., Berg, B., Harris, A., Lundin, S. (1987) Subcutaneous and intranasal administration of 1-deamino-8-D-arginine vasopressin in the assessment of renal concentration capacity. Nephron 45: 27-30
29. Vilhardt, H., Lundin, S. (1986) Biological effect and plasma concentrations of DDAVP after intranasal and peroral administration to humans. Gen. Pharmacol. 17: 481-483
30. Wang, Y. X., Crofton, J. T., Share, L. (1997) Sex differences in the cardiovascular and renal actions of vasopressin in conscious rats. Am. J. Physiol. 272: R370-R376